Torrent Pharmaceuticals Share Price Target 2025, 2026, 2030, 2040, 2050

Torrent Pharmaceuticals, started by Late Shri U. N. Mehta in Ahmedabad, Gujarat. It is a big Indian medicine company and part of the Torrent Group. It sells its medicines in more than 40 countries. The company mainly makes medicines for long-term health problems, such as heart diseases, brain and nerve issues, stomach and digestive problems, and women’s health needs. It also makes medicines for diabetes, pain, cancer, infections, and gynaecology. It is known for its strong research team, modern and high-quality factories, and smart business deals that help it grow.

What is Torrent Pharmaceuticals Ltd NSE: TORNTPHARM?

Torrent Pharmaceuticals, established in 1959 in Ahmedabad, Gujarat, and owned by the Torrent Group (led by Sudhir and Samir Mehta), is one of India’s big and well-known medicine companies. It makes many types of medicines for heart problems, brain and nerve issues, diabetes, infections, digestion, pain, cancer, and other common health needs. The company has good research teams and modern factories that help create safe and useful medicines. It sells its products all over India and in more than 50 countries, making it an important company that helps people get the medicines they need.

Torrent Pharmaceuticals Share Price Target

Torrent Pharmaceuticals Share Price Target 2025

It is one of India’s top medicine companies. It started as a small local business and slowly grew into a big global brand. The company makes many types of medicines for different health problems. Over time, it has built a strong name. The company mainly focus on good quality, research, and long-term treatments. Today, its medicines are used by millions of people in India and many other countries. It is known for its trusted products and its goal of improving people’s health around the world. In 2025, its share price target would be ₹4221, as per stock market analysts.

According to stock market analysts, its share price would be between ₹2886 to ₹4221 in 2025.

Year	Minimum Price (Rs)	Maximum Price (Rs)
2025	2886	4221

Month	Minimum Price  (Rs)	Maximum Price (Rs)
January	3122	3465
February	2911	3332
March	2886	3300
April	3107	3360
May	3101	3371
June	3102	3478
July	3287	3787
August	3490	3740
September	3483	3679
October	3480	3685
November	3314	4046
December	3320	4221

Torrent Pharmaceuticals Share Price Target 2026

It works in many important medical fields. Its focus is on long-term diseases like heart problems, brain and nerve disorders, stomach and digestive issues, and women’s health. These health problems need medicines for many years, and it has strong and trusted brands in these areas. Along with this, the company also makes medicines for diabetes, cancer, infections, pain, and gynaecology. The company supports a large number of patients who need safe and effective medicines. In 2026, its share price target would be ₹5342, as per stock market analysts.

According to stock market analysts, its share price would be between ₹3900 to ₹5342 in 2026.

Year	Minimum Price (Rs)	Maximum Price (Rs)
2026	3900	5342

Month	Minimum Price  (Rs)	Maximum Price (Rs)
January	3900	4325
February	4035	4484
March	4090	4571
April	4178	4641
May	4225	4690
June	4315	4756
July	4421	4835
August	4525	4887
September	4625	4900
October	4675	4990
November	4712	5187
December	4865	5342

Share Price Target 2027

It focuses on specific therapy areas instead of making every type of medicine. This approach is called niche marketing. The company chooses a few important medical areas and tries to become a leader in them. This helps the company to understand what doctors and patients really need. It also helps the company invest more in research and build stronger brands. This strategy has made it a top player in heart care, brain care, digestion, and women’s health in India and in several other countries. In 2027, its share price target would be ₹6322, as per stock market analysts.

According to stock market analysts, its share price would be between ₹5257 to ₹6322 in 2027.

Year	Minimum Price (Rs)	Maximum Price (Rs)
2027	5257	6322

Share Price Target 2028

It has a strong business network across India. It works with thousands of distributors, dealers, and medical stores. The company has many sales teams that meet doctors, clinics, and hospitals in both big cities and small towns. Its medicines are easily available, making it simple for patients to buy what they need. The company also teaches healthcare professionals about its medicines to ensure they are used safely. This wide network has helped Torrent become one of the most trusted pharma companies in India. In 2028, its share price target would be ₹7228, as per stock market analysts.

According to stock market analysts, its share price would be between ₹6184 to ₹7228 in 2028.

Year	Minimum Price (Rs)	Maximum Price (Rs)
2028	6184	7228

Share Price Target 2029

It has many modern and advanced manufacturing plants in India. These plants use high-quality machines, strict safety rules, and careful testing methods to make sure every medicine is safe and effective. Some plants produce tablets and capsules, while others make the raw materials needed for medicines. All facilities follow strict global rules, which allow them to supply medicines to regulated countries like the US and Europe. In 2029, its share price target would be ₹8115, as per stock market analysts.

According to stock market analysts, its share price would be between ₹7100 to ₹8115 in 2029.

Year	Minimum Price (Rs)	Maximum Price (Rs)
2029	7100	8115

Torrent Pharmaceuticals share price Target 2030

It spends a lot of money on research and development (R&D) to make better medicines. Its R&D teams work on developing new drug formulas, improving existing products, and ensuring safety. The company uses modern labs and advanced technology to stay competitive. It launches new medicines in its main therapy areas and also enters new disease segments with the help of its R&D team. In 2030, its share price target would be ₹8984, as per stock market analysts.

According to stock market analysts, its share price would be between ₹8005 to ₹8984 in 2030.

Year	Minimum Price (Rs)	Maximum Price (Rs)
2030	8005	8984

Month	Minimum Price  (Rs)	Maximum Price (Rs)
January	8005	8357
February	8042	8390
March	8068	8475
April	8120	8565
May	8178	8590
June	8225	8615
July	8365	8678
August	8410	8735
September	8452	8775
October	8479	8810
November	8552	8855
December	8615	8984

Share Price Target 2040

Today, it is among India’s top pharma companies. Its strong focus on long-term diseases like heart, nerve, and digestive problems has made it a trusted name among doctors and patients. The company stands out because of its high-quality medicines, wide distribution network, and steady performance. It has built a strong reputation for reliability and patient care. This position helps it compete well with both Indian and international pharmaceutical brands. In 2040, its share price target would be ₹15321, as per stock market analysts.

According to stock market analysts, its share price would be between ₹13658 to ₹15321 in 2040.

Year	Minimum Price (Rs)	Maximum Price (Rs)
2040	13658	15321

Month	Minimum Price  (Rs)	Maximum Price (Rs)
January	13658	13931
February	13721	14125
March	13812	14221
April	13885	14335
May	13985	14398
June	14110	14458
July	14158	14568
August	14235	14687
September	14284	14785
October	14458	14968
November	14658	15125
December	14874	15321

Share Price Target 2050

It aims to become one of the most respected global pharma companies. Its mission is to provide safe, high-quality, and effective medicines that improve people’s lives. The company plans to grow by increasing its research work, expanding into global markets, and building new manufacturing facilities. It also wants to enter more medical areas and offer advanced healthcare solutions. With a strong focus on innovation, quality, and patient well-being, the company hopes to help even more people live healthier lives in the future. In 2050, its share price target would be ₹20216, as per stock market analysts.

According to stock market analysts, its share price would be between ₹19153 to ₹20216 in 2050.

Year	Minimum Price (Rs)	Maximum Price (Rs)
2050	19153	20216

Month	Minimum Price  (Rs)	Maximum Price (Rs)
January	19153	19421
February	19254	19587
March	19358	19688
April	19458	19758
May	19568	19856
June	19689	19935
July	19874	20125
August	19921	20255
September	20020	20358
October	20090	20474
November	21120	20568
December	21251	20689

Should I buy Torrent Pharmaceuticals stock?

Year	Minimum Price (Rs)	Maximum Price (Rs)
2025	2886	4221
2026	3900	5342
2027	5257	6322
2028	6184	7228
2029	7100	8115
2030	8005	8984
2040	13658	15321
2050	19153	20216

This stock can be a good choice for long-term investment. The company is strong because it makes important medicines for long-term health problems, has good research teams, sells products in many countries, and has steady demand. This helps the company grow over time. It has also bought other companies to get bigger. If you want stable growth and can handle some risk, it might be suitable, but you should check your finances and understand the risks before buying.

Torrent Pharmaceuticals earnings results

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Sales +	7,939	8,005	8,508	9,620	10,728	11,516	12,248
Expenses +	5,769	5,524	6,077	6,778	7,360	7,795	8,255
Operating Profit	2,170	2,480	2,431	2,842	3,368	3,721	3,993
OPM %	27%	31%	29%	30%	31%	32%	33%
Other Income +	121	57	-288	45	146	-1	-86
Interest	451	353	255	333	354	252	217
Depreciation	654	658	662	707	808	795	805
Profit before tax	1,187	1,526	1,226	1,847	2,352	2,673	2,885
Tax %	14%	18%	37%	33%	30%	28%
Net Profit +	1,025	1,252	777	1,245	1,656	1,911	2,140
EPS in Rs	30.28	36.99	22.97	36.79	48.94	56.47	63.22
Dividend Payout %	53%	47%	105%	60%	57%	57%

Key Metrics

TTM PE Ratio	PB Ratio	Dividend Yield	Sector PE	Sector PB	Sector Div Yld
59.40	16.75	0.85%	37.17	5.87	0.58%

Peers & Comparison

Stock	PE Ratio	PB Ratio	Dividend Yield
Torrent Pharmaceuticals Ltd	66.51	16.75	0.85%
Sun Pharmaceutical Industries Ltd	39.62	5.97	0.89%
Cipla Ltd	23.35	3.93	1.05%
Dr Reddy’s Laboratories Ltd	18.37	3.06	0.64%

Is Torrent Pharmaceuticals stock good to buy? (bull case & bear case)

Bull Case:

• Its revenue grew to ₹3,178 crore in Q1 FY26 from ₹2,790 crore last year, showing it is making more money.
• Net profit increased about 30% year-on-year in Q2 FY26 to ₹537 crore, demonstrating strong earnings.
• The company focuses on long-term medicines for the heart, digestion, brain, and women’s health, which people need regularly.
• Buying other companies, like JB Chemicals, can help Torrent sell more products and reach more markets.
• Strong research teams and modern factories allow Torrent to make new medicines and maintain high quality.

Bear Case:

• The stock price is already high, which may limit short-term gains.
• Joining new companies, like JB Chemicals, may have problems and reduce profits.
• Changes in government rules, more competition, or currency issues could lower earnings.

Conclusion

It is a top medicine company in India. It makes medicines for the heart, brain, digestion, women’s health, and other long-term health problems. The company has strong research teams, modern factories, and sells its products in over 50 countries, which has made it trusted by many people. Experts expect the company to grow steadily with new medicines and by buying other companies. The stock is a bit expensive and faces competition and government rules, but its steady earnings and focus on long-term medicines make it a good choice for investors who can take some risk.

FAQs